Filana Therapeutics, Inc. (FLNA)
1.955
-0.04
(-1.76%)
USD |
NASDAQ |
Mar 16, 16:00
1.97
+0.02
(+0.77%)
After-Hours: 18:49
Filana Therapeutics EPS Diluted (Quarterly) : -0.2596 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| cbdMD, Inc. | -0.036 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Amicus Therapeutics, Inc. | 0.0054 |
| NovaBay Pharmaceuticals, Inc. | -1.100 |
| Spero Therapeutics, Inc. | -0.1312 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.54M |
| Total Expenses (Quarterly) | 12.54M |
| Enterprise Value | 0.6307M |
| Earnings Yield | -96.35% |
| Normalized Earnings Yield | -96.35 |